L2 Medical Development Company — US29278A1016
Source record · L2 Medical Development Company — US29278A1016
- ISIN
- US29278A1016
- Issuer LEI
- 549300MGDCSOPC4J8L71
- Issuer
- L2 Medical Development Company
- Prefix
- US
- Country
- United States
- National code
- 29278A101
- Check digit
- 6 (verifies)
- CUSIP
- 29278A101
- Handle
- #://US29278A1016
- Edition address
- web+usd://isin-us29278a1016
- GTIN
- 29788080964997
Source · https://mapping.gleif.org/api/v2/isin-lei?page%5Bnumber%5D=1&page%5Bsize%5D=1
Retrieved · 2026-10-20T03:05:37.603Z
ISIN US29278A1016 edition: identity from GLEIF/ANNA (CC0); no valuation or affiliation implied. CUSIP 29278A101 is derived from the ISIN itself.